Prostate cancer: 6. Surgical treatment of localized disease

Autor Goldenberg, S L, Ramsey, E W, Jewett, M A
Vydáno 1998

Prostate cancer: 2. Natural history

Autor Nam, R K, Jewett, M A, Krahn, M D
Vydáno 1998

Exocrine function of testis with germinal testicular tumour.

Autor Jewett, M A, Thachil, J V, Harris, J F
Vydáno 1983

Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.

Autor Teodorczyk-Injeyan, J, Jewett, M A, Burke, C A, Ostrand-Rosenberg, S
Vydáno 1980

Association of germ cell tumours of the testis and intrathoracic sarcoid-like lesions.

Autor Urbanski, S J, Alison, R E, Jewett, M A, Gospodarowicz, M K, Sturgeon, J F
Vydáno 1987

Prevalence of geriatric urinary dysfunction in a chronic care hospital.

Autor Fernie, G. R., Jewett, M. A., Autry, D., Holliday, P. J., Zorzitto, M. L.
Vydáno 1983

The use of cryopreserved lymphocytes for longitudinal studies of immune function and enumeration of subpopulations.

Autor Jewett, M A, Gupta, S, Hansen, J A, Cunningham-Rundles, S, Siegal, F P, Good, R A, Dupont, B
Vydáno 1976

An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta H...

Autor Munro, A. J., Nielsen, O. S., Duncan, W., Sturgeon, J., Gospodarowicz, M. K., Malkin, A., Thomas, G. M., Jewett, M. A.
Vydáno 1991

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Autor Hermanns, T, Bhindi, B, Wei, Y, Yu, J, Noon, A P, Richard, P O, Bhatt, J R, Almatar, A, Jewett, M A S, Fleshner, N E, Zlotta, A R, Templeton, A J, Kulkarni, G S
Vydáno 2014

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

Autor White, N M A, Khella, H W Z, Grigull, J, Adzovic, S, Youssef, Y M, Honey, R J, Stewart, R, Pace, K T, Bjarnason, G A, Jewett, M A S, Evans, A J, Gabril, M, Yousef, G M
Vydáno 2011

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma

Autor Hotte, S.J., Bjarnason, G.A., Heng, D.Y.C., Jewett, M.A.S., Kapoor, A., Kollmannsberger, C., Maroun, J., Mayhew, L.A., North, S., Reaume, M.N., Ruether, J.D., Soulieres, D., Venner, P.M., Winquist, E.W., Wood, L., Yong, J.H.E., Saad, F.
Vydáno 2011

Somatic mutations of KIT in familial testicular germ cell tumours

Autor Rapley, E A, Hockley, S, Warren, W, Johnson, L, Huddart, R, Crockford, G, Forman, D, Leahy, M G, Oliver, D T, Tucker, K, Friedlander, M, Phillips, K-A, Hogg, D, Jewett, M A S, Lohynska, R, Daugaard, G, Richard, S, Heidenreich, A, Geczi, L, Bodrogi, I, Olah, E, Ormiston, W J, Daly, P A, Looijenga, L H J, Guilford, P, Aass, N, Fosså, S D, Heimdal, K, Tjulandin, S A, Liubchenko, L, Stoll, H, Weber, W, Einhorn, L, Weber, B L, McMaster, M, Greene, M H, Bishop, D T, Easton, D, Stratton, M R
Vydáno 2004

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

Autor Pouessel, D., Neuzillet, Y., Mertens, L. S., van der Heijden, M. S., de Jong, J., Sanders, J., Peters, D., Leroy, K., Manceau, A., Maille, P., Soyeux, P., Moktefi, A., Semprez, F., Vordos, D., de la Taille, A., Hurst, C. D., Tomlinson, D. C., Harnden, P., Bostrom, P. J., Mirtti, T., Horenblas, S., Loriot, Y., Houédé, N., Chevreau, C., Beuzeboc, P., Shariat, S. F., Sagalowsky, A. I., Ashfaq, R., Burger, M., Jewett, M. A. S., Zlotta, A. R., Broeks, A., Bapat, B., Knowles, M. A., Lotan, Y., van der Kwast, T. H., Culine, S., Allory, Y., van Rhijn, B. W. G.
Vydáno v Ann Oncol (2016)